Disease | myelofibrosis |
Comorbidity | C0026986|myelodysplastic syndrome |
Sentences | 9 |
PubMedID- 23882429 | However, the patient developed myelodysplastic syndrome (mds) raeb-2 with myelofibrosis after remission, possibly because of chemotherapy or dna methylation. |
PubMedID- 24186132 | In this study, we assessed the prognostic impact of bone marrow fibrosis in patients with primary myelodysplastic syndromes under the recently revised new risk stratification systems: the new comprehensive cytogenetic scoring system and the revised international prognostic scoring system. |
PubMedID- 21282718 | myelodysplastic syndromes with bone marrow fibrosis. |
PubMedID- 23660629 | The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. |
PubMedID- 26171043 | Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: a case report. |
PubMedID- 20971823 | Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. |
PubMedID- 22781796 | Objective: to analyze the clinical features and prognosis of the primary myelodysplastic syndrome with myelofibrosis (mds-mf) patients and to improve the cognition of mds-mf. |
PubMedID- 24809010 | myelodysplastic syndromes with myelofibrosis (mds-f) is a poor prognostic hematopoietic disorder. |
PubMedID- 22937321 | A diagnosis of myelodysplastic syndrome (mds) with myelofibrosis was rendered. |
Page: 1